Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artemis Capital Partners is a Boston-based private equity firm that invests in and builds specialized industrial technology companies rather than operating as a drug developer or healthcare services company. The firm focuses on differentiated manufacturers and technology businesses serving end markets such as life sciences, diagnostics, aerospace, and defense. Within life-science-adjacent markets, Artemis has backed companies supplying laboratory automation, instrumentation, and related industrial technologies, including Millrock Technology in lyophilization equipment. Artemis provides buyout and growth equity capital along with operational support to portfolio companies. It should be classified primarily as an investor with exposure to life sciences tools and industrial tech, not as a biotech or pharma pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artemis Capital Partners.